✦ LIBER ✦

Clinical experience of MEK inhibitors in cancer therapy

✍ Scribed by Ding Wang; Scott A. Boerner; James D. Winkler; Patricia M. LoRusso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

From basic research to clinical developm

✍ Christophe Frémin; Sylvain Meloche 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 1009 KB

The clinical development of MEK inhibito

✍ Zhao, Yujie; Adjei, Alex A. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 918 KB

23 Clinical Status of RAF/MEK Inhibitors

✍ Weber, J.; Daud, A.; Infante, J.; Sosman, J.; Flaherty, K.; Kefford, R.; Hamid, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Clinical Potential of Matrix Metalloprot

✍ Dr Elisabeth I. Heath, Louise B. Grochow 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 215 KB

Clinical importance of DNA repair inhibi

✍ N. Hosoya; K. Miyagawa 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 319 KB

Histone Deacetylase Inhibitors in Cancer

✍ Lane, Andrew A. (author);Chabner, Bruce A. (author) 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB